JD Health International Inc (JDHIY) Fair Value & Analysis
Healthcare · US · Market cap $17.0B
JD Health International Inc
JDHIY · US
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from $8.78 to $6.93 (−21.1%) since Jun 23, 2026. Share price −20.4% over the past month.
Price vs Fair Value (12 months)
12‑month range $4.26 – $9.08 · fair‑value band $3.64 – $9.01 · the $4.26 price screens below the $6.93 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
JD Health International Inc (JDHIY) currently trades at $4.26, while our model-based Fair Value estimate is $6.93 — implying the stock looks roughly 62.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, JD Health International Inc generated revenue of $73.4B at a net margin of 7.3%. Revenue grew 28.0% year over year. It earns a return on equity of 9.3%. The balance sheet holds a net cash position of $31.2B. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it p…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
JD Health International Inc reported revenue of $71.4B in FY2025 versus $30.7B in FY2021, a compound +23.5%/yr. Reported net income was $5.2B in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Alibaba Health Information Technology Limited ALBBY | $8.27 | $6.61 | -20% |
| Raia Drogasil S.A RADL3 | R$17.76 | R$14.97 | -16% |
| Yifeng Pharmacy Chain Co 603939 | ¥19.75 | ¥40.59 | +106% |
| Clicks Group CLCGY | $27.97 | $34.29 | +23% |
| Sugi Holdings SGIPF | $16.29 | $32.19 | +98% |
| Corporativo Fragua, S.A. CGSBF | $29.66 | $40.13 | +35% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is JD Health International Inc (JDHIY) undervalued?
What is the fair value of JDHIY?
What is the quality score of JDHIY?
What is the revenue of JD Health International Inc (JDHIY)?
What is the net profit margin of JDHIY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.